Lurasidone HCL - A 6-week Phase 3 Study of Patients With Acute Schizophrenia.
Public ClinicalTrials.gov record NCT00790192. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3 Randomized, Double-Blind, Placebo- and Active Comparator-Controlled Clinical Trial to Study the Efficacy and Safety of Two Doses of Lurasidone in Acutely Psychotic Subjects With Schizophrenia (PEARL 3)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Lurasidone HCl is a compound being developed for the treatment of schizophrenia. This clinical study is designed to test the hypothesis that lurasidone is effective, tolerable, and safe as compared with quetiapine XR short term among acutely psychotic patients with chronic schizophrenia.
Study identification
- NCT ID
- NCT00790192
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 488 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 2008 (Type not available)
- Primary completion
- Jul 2010 (Actual)
- Completion
- Jul 2010 (Actual)
- Last update posted
- Mar 17, 2016
2008 – 2010
United States locations
- U.S. sites
- 29
- U.S. states
- 12
- U.S. cities
- 26
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| K&S Professional Research Services, LLC | Little Rock | Arkansas | 72201 | — |
| Woodland International Research Group | Little Rock | Arkansas | 72211 | — |
| Clinical Pharmacological Studies, Inc. | Cerritos | California | 90703 | — |
| Comprehensive Neuroscience, Inc | Cerritos | California | 90703 | — |
| Clinical Innovations, Inc. | Costa Mesa | California | 92647 | — |
| Synergy Escondido | Escondido | California | 92025 | — |
| Collaborative Neuroscience Network | Garden Grove | California | 92645 | — |
| Apostle Clinical Trials, Inc. | Long Beach | California | 90813 | — |
| California Clinical Trials | Paramount | California | 90723 | — |
| Pasadena Research Institute | Pasadena | California | 91107 | — |
| CNRI-Los Angeles. LLC | Pico Rivera | California | 90660 | — |
| Clinical Innovations, Inc. | Riverside | California | 92647 | — |
| CNRI-San Diego | San Diego | California | 92126 | — |
| UCSD Medical Center | Sandeigo | California | 92103 | — |
| Segal Institute for Clinical Research | Highlands Ranch | Colorado | 80103 | — |
| Comprehensive Neuroscience, Inc. | Washington D.C. | District of Columbia | 20016 | — |
| Florida Clinical Research Center | Bradenton | Florida | 34208 | — |
| Florida Clinical Research Center, LLC | Fruitland Park | Florida | 34731 | — |
| Lake Charles Clinical Trials | Lake Charles | Louisiana | 70601 | — |
| Booker, J. Gary, MD. APMC | Shreveport | Louisiana | 71104 | — |
| Precise Clinical Research | Flowood | Mississippi | 39232 | — |
| St. Charles Psychiatric Associates | Saint Charles | Missouri | 63301 | — |
| St. Louis Research, Inc. | St Louis | Missouri | 63118 | — |
| CRI Worldwide | Willingboro | New Jersey | 08046 | — |
| Comprehensive Neuroscience, Inc | Holliswood | New York | 11423 | — |
| Segal Institute for Clinical Research | Winston-Salem | North Carolina | 27104 | — |
| Community Clinical Research | Austin | Texas | 78729 | — |
| Future Search Trials of Neurology | Austin | Texas | 78756 | — |
| Pillar Clinical Research | Dallas | Texas | 75243 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 36 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00790192, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 17, 2016 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00790192 live on ClinicalTrials.gov.